CRC
SLNO

Curi RMB Capital’s Soleno Therapeutics SLNO Stock Holding History

Curi RMB Capital’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,794
Closed -$324K – 896
2025
Q3 		$324K Sell
4,794
-5
-0.1% -$371 0.01% 588
2025
Q2 		$402K Buy
+4,799
New +$359K 0.01% 543
2024
Q4 		– Sell
-4,000
Closed -$202K – 552
2024
Q3 		$202K Buy
+4,000
New +$191K ﹤0.01% 533

Other funds holding SLNO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Curi RMB Capital's SLNO Position: Q4 2025 in Review

Curi RMB Capital sold out of Soleno Therapeutics (SLNO) in Q4 2025, closing a stake of 4,794 shares — an estimated $324K sold.

Curi RMB Capital first reported a position in SLNO in Q3 2024 and held it in 3 quarters. The position peaked at $402K in Q2 2025. 248 funds tracked by Wall St. Rank hold SLNO as of Q4 2025.

  • Curi RMB Capital reported no remaining Soleno Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Curi RMB Capital sold 4,794 Soleno Therapeutics shares in Q4 2025, an estimated $324K.
  • Curi RMB Capital first reported a position in Soleno Therapeutics in Q3 2024 and held it in 3 quarters.
  • Curi RMB Capital's Soleno Therapeutics position peaked at $402K in Q2 2025.
  • 248 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q4 2025.

Based on Curi RMB Capital's 13F filing for Q4 2025, filed 17 Feb 2026.